top of page
fnjfn.png

Ron Rocca

Mr. Rocca brings over two decades of biotech, Pharma and diagnostics industry experience, including eleven years of developing and commercializing diagnostic products for autoimmune-related diseases. He currently serves as President and Chief Executive Officer of Mindera Health.

 

His prior role was President and CEO of Exagen Inc. (NASDAQ: XGN) which commercialized a suite of testing products enabling healthcare 

Ron Rocca

providers to improve care for patients through the differential diagnosis and prognosis. Prior to Exagen, Mr. Rocca served as GM, at Prometheus Laboratories, Inc., a specialty pharmaceutical and diagnostic company focused on diseases in gastroenterology and oncology. Earlier in his career, Mr. Rocca served in senior sales and marketing management positions for Elan Pharmaceuticals. 
 

Mr. Rocca received a B.A. in Marketing and Personnel Management from Towson University. In addition to Circular Genomics, Mr. Rocca also is a Board member at Interpace Diagnostics.

bottom of page